LUPIN.NS
Price:
$2098.8
Market Cap:
$958.65B
Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, and anti-tuberculosis. The company is also involved in the provision of biosimilar and over-the-counter products; specialty products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as b...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2001-09-10
Stock Exchange
NSE
Ticker
LUPIN.NS
According to Lupin Limited’s latest financial reports and current stock price. The company's current ROE is 24.77%. This represents a change of 304.21% compared to the average of 6.13% of the last 4 quarters.
The mean historical ROE of Lupin Limited over the last ten years is 7.55%. The current 24.77% ROE has changed 228.11% with respect to the historical average. Over the past ten years (40 quarters), LUPIN.NS's ROE was at its highest in in the June 2016 quarter at 8.01%. The ROE was at its lowest in in the September 2021 quarter at -17.54%.
Average
7.55%
Median
6.61%
Minimum
-12.57%
Maximum
20.25%
Discovering the peaks and valleys of Lupin Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 288.27%
Maximum Annual ROE = 20.25%
Minimum Annual Increase = -510.15%
Minimum Annual ROE = -12.57%
| Year | ROE | Change |
|---|---|---|
| 2025 | 19.08% | 42.38% |
| 2024 | 13.40% | 288.27% |
| 2023 | 3.45% | -127.44% |
| 2022 | -12.57% | -242.66% |
| 2021 | 8.81% | -510.15% |
| 2020 | -2.15% | -148.68% |
| 2019 | 4.41% | 138.50% |
| 2018 | 1.85% | -90.23% |
| 2017 | 18.95% | -6.44% |
| 2016 | 20.25% | -25.22% |
The current ROE of Lupin Limited (LUPIN.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.97%
5-year avg
6.43%
10-year avg
7.55%
Lupin Limited’s ROE is less than Zydus Lifesciences Limited (19.72%), less than Zydus Lifesciences Limited (19.72%), less than Dr. Reddy's Laboratories Limited (17.25%), less than Dr. Reddy's Laboratories Limited (17.25%), less than Mankind Pharma Limited (12.74%), less than Mankind Pharma Limited (12.74%), less than Aurobindo Pharma Limited (10.43%), less than Alkem Laboratories Limited (19.01%), less than Alkem Laboratories Limited (19.01%), less than Aurobindo Pharma Limited (10.43%),
| Company | ROE | Market cap |
|---|---|---|
| 19.72% | $937.26B | |
| 19.72% | $937.26B | |
| 17.25% | $1.06T | |
| 17.25% | $1.06T | |
| 12.74% | $910.44B | |
| 12.74% | $910.01B | |
| 10.43% | $707.18B | |
| 19.01% | $678.59B | |
| 19.01% | $680.24B | |
| 10.43% | $707.10B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lupin Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lupin Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Lupin Limited's ROE?
How is the ROE calculated for Lupin Limited (LUPIN.NS)?
What is the highest ROE for Lupin Limited (LUPIN.NS)?
What is the 3-year average ROE for Lupin Limited (LUPIN.NS)?
What is the 5-year average ROE for Lupin Limited (LUPIN.NS)?
How does the current ROE for Lupin Limited (LUPIN.NS) compare to its historical average?